[(2S)-2-[(4R)-2-amino-4-[4-[1-(difluoromethyl)pyrazol-4-yl]phenyl]-4-(2,2-dimethylpropyl)-5-oxoimidazol-1-yl]-2-[3-(5-cyclopropyl-1,2,4-triazol-1-yl)-4-(trifluoromethoxy)phenyl]ethyl] 2-(1-methylcyclopropyl)acetate
C38H41F5N8O4 — CID 160603417
Data last refreshed: (MolForge compound catalog, from PubChem)
About [(2S)-2-[(4R)-2-amino-4-[4-[1-(difluoromethyl)pyrazol-4-yl]phenyl]-4-(2,2-dimethylpropyl)-5-oxoimidazol-1-yl]-2-[3-(5-cyclopropyl-1,2,4-triazol-1-yl)-4-(trifluoromethoxy)phenyl]ethyl] 2-(1-methylcyclopropyl)acetate
[(2S)-2-[(4R)-2-amino-4-[4-[1-(difluoromethyl)pyrazol-4-yl]phenyl]-4-(2,2-dimethylpropyl)-5-oxoimidazol-1-yl]-2-[3-(5-cyclopropyl-1,2,4-triazol-1-yl)-4-(trifluoromethoxy)phenyl]ethyl] 2-(1-methylcyclopropyl)acetate (PubChem CID 160603417) has the molecular formula C38H41F5N8O4 and a molecular weight of 768.79 g/mol. Its IUPAC name is [(2S)-2-[(4R)-2-amino-4-[4-[1-(difluoromethyl)pyrazol-4-yl]phenyl]-4-(2,2-dimethylpropyl)-5-oxoimidazol-1-yl]-2-[3-(5-cyclopropyl-1,2,4-triazol-1-yl)-4-(trifluoromethoxy)phenyl]ethyl] 2-(1-methylcyclopropyl)acetate.
Molecular Properties
| Compound Name | [(2S)-2-[(4R)-2-amino-4-[4-[1-(difluoromethyl)pyrazol-4-yl]phenyl]-4-(2,2-dimethylpropyl)-5-oxoimidazol-1-yl]-2-[3-(5-cyclopropyl-1,2,4-triazol-1-yl)-4-(trifluoromethoxy)phenyl]ethyl] 2-(1-methylcyclopropyl)acetate |
|---|---|
| PubChem CID | 160603417 |
| Molecular Formula | C38H41F5N8O4 |
| Molecular Weight | 768.79 g/mol |
| Exact Mass | 768.32 |
| IUPAC Name | [(2S)-2-[(4R)-2-amino-4-[4-[1-(difluoromethyl)pyrazol-4-yl]phenyl]-4-(2,2-dimethylpropyl)-5-oxoimidazol-1-yl]-2-[3-(5-cyclopropyl-1,2,4-triazol-1-yl)-4-(trifluoromethoxy)phenyl]ethyl] 2-(1-methylcyclopropyl)acetate |
| SMILES | CC(C)(C)C[C@]1(c2ccc(-c3cnn(C(F)F)c3)cc2)N=C(N)N([C@H](COC(=O)CC2(C)CC2)c2ccc(OC(F)(F)F)c(-n3ncnc3C3CC3)c2)C1=O |
| InChI | InChI=1S/C38H41F5N8O4/c1-35(2,3)20-37(26-10-7-22(8-11-26)25-17-46-49(18-25)33(39)40)32(53)50(34(44)48-37)28(19-54-30(52)16-36(4)13-14-36)24-9-12-29(55-38(41,42)43)27(15-24)51-31(23-5-6-23)45-21-47-51/h7-12,15,17-18,21,23,28,33H,5-6,13-14,16,19-20H2,1-4H3,(H2,44,48)/t28-,37-/m1/s1 |
| InChIKey | FFMQVAAXYNBCBL-KWXDVARASA-N |
| XLogP | 7.57 |
| TPSA | 142.75 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 11 |
| Rotatable Bonds | 13 |
| Heavy Atoms | 55 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 768.79 |
| LogP ≤ 5 | 7.57 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 11 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 160603417 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.